Murata, S.; Nakamura, M.; Sugihara, K.; Sakai, T.; Ishioka, K.; Takahashi, S.; Sasada, S.; Yasuda, H.; Fukunaga, K. The Change in Neutrophil-to-Lymphocyte Ratio After Initiation of Nivolumab Monotherapy May Be a Strong Marker of Response and Predictor of Prognosis in Advanced Non-Small Cell Lung Carcinoma. apjcc 2022, 7, 191-196.